Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
120M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
2.12M
-
Shares change
-
+19K
-
Total reported value, excl. options
-
$12.8M
-
Value change
-
+$115K
-
Number of buys
-
7
-
Number of sells
-
-1
-
Price
-
$6.01
Significant Holders of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) as of Q1 2020
15 filings reported holding IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value as of Q1 2020.
IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.12M shares
of 120M outstanding shares and own 1.76% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (1.37M shares), Artal Group S.A. (630K shares), RENAISSANCE TECHNOLOGIES LLC (67.9K shares), VANGUARD GROUP INC (11.5K shares), Verition Fund Management LLC (11.3K shares), WELLS FARGO & COMPANY/MN (10.8K shares), MILLENNIUM MANAGEMENT LLC (10.3K shares), UBS Group AG (3.2K shares), BANK OF AMERICA CORP /DE/ (2.57K shares), and Tower Research Capital LLC (TRC) (2.1K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.